Home
Conditions
Hematologic Neoplasms

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

1,027 public trials 268 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Active, Not Recruiting

Evaluation of Safety, Tolerance, and Efficacy of Allogeneic LB-DTK-COV19 in Severe Coronavirus Disease 2019 Patients

NCT07709637

Conditions: COVID-19, COVID-19 (SARS-CoV-2 Infection), Coronaviridae Infections, +18 more
Locations: The Catholic University of Korea Seoul St.Mary's Hospital Seoul, South Korea

View Trial Details

Active, Not Recruiting

Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer

NCT01949662

Conditions: Advanced Cancers, Chemically-Induced Disorders, Confusion, +15 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Testing Trametinib as a Potential Targeted Treatment in Cancers With NF1 Genetic Changes (MATCH-Subprotocol S1)

NCT04439318

Conditions: Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Blood Protein Disorders, +22 more
Locations: ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

Testing Trametinib as a Potential Targeted Treatment in Cancers With GNAQ or GNA11 Genetic Changes (MATCH-Subprotocol S2)

NCT04439357

Conditions: Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Blood Protein Disorders, +22 more
Locations: ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

Gardasil 9 Vaccine in Preventing HPV Infection in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

NCT03023631

Conditions: Allogeneic Hematopoietic Stem Cell Transplant Recipient, Hematologic Diseases, Hematologic Neoplasms, +4 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Well-Being and Health-Related Quality of Life in Cancer Patients and Survivors During the COVID-19 Pandemic

NCT04500600

Conditions: COVID-19, COVID-19 Infection, Coronaviridae Infections, +17 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Hu8F4 in Treating Patients With Advanced Hematologic Malignancies

NCT02530034

Conditions: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Blast Crisis, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, +31 more
Locations: Augusta University Augusta, Georgia, United States

Montefiore Medical Center, Albert Einstein College of Medicine The Bronx, New York, United States

M D Anderson Cancer Center Houston, Texas, United States

Huntsman Cancer Institute Salt Lake City, Utah, United States

View Trial Details

Active, Not Recruiting

Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in Participants With Relapsed or Refractory Multiple Myeloma

NCT03145181

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +3 more
Locations: City of Hope Duarte, California, United States

Colorado Blood Cancer Institute Denver, Colorado, United States

Icahn School of Medicine at Mount Sinai Program for the Protection of Human Subjects New York, United States

Levine Cancer Institute Charlotte, North Carolina, United States

View all 13 locations

View Trial Details

Active, Not Recruiting

Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant

NCT04177004

Conditions: Allogeneic Hematopoietic Stem Cell Transplant Recipient, Hematologic Diseases, Hematologic Neoplasms, +4 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes

NCT03399773

Conditions: Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Anemia, +29 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Hematologic Neoplasms

Hematologic Neoplasms trial results

Related conditions